,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-02-23 05:20:00,"Chicago, IL - February 23, 2018 - Zacks.com announces the list of stocks featured in the Analyst Blog.",0.01732461340725422,0.008937835693359375,0.9737375974655151,neutral,0.008386777713894844
1,2018-02-23 05:20:00,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2018-02-23 05:20:00,"Stocks recently featured in the blog include Home DepotHD , GlaxoGSK , MarriottMAR , DISH NetworkDISH and O'Reilly AutomotiveORLY .",0.02428041771054268,0.01420283131301403,0.961516797542572,neutral,0.010077586397528648
3,2018-02-23 05:20:00,"Here are highlights from Thursday's Analyst Blog:

The Zacks Research Daily presents the best research output of our analyst team.",0.2266942709684372,0.009645335376262665,0.7636604309082031,neutral,0.21704894304275513
4,2018-02-23 05:20:00,"Today's Research Daily features new research reports on 16 major stocks, including Home Depot, Glaxo and Marriott.",0.04004485532641411,0.009355456568300724,0.950599730014801,neutral,0.03068939968943596
5,2018-02-23 05:20:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
6,2018-02-23 05:20:00,"Home Depot 's shares have gained +26.5% over the last one year, outperforming the Zacks Retail Building Products industry's +23.5% increase backed by its five-year long trend of beating earnings estimates, which continued in fourth-quarter fiscal 2017.",0.9556910991668701,0.02644292078912258,0.017865944653749466,positive,0.9292481541633606
7,2018-02-23 05:20:00,"Further, sales topped estimates for the sixth straight quarter.",0.9483886957168579,0.02079685777425766,0.0308143999427557,positive,0.927591860294342
8,2018-02-23 05:20:00,"Results gained from strength in core business as well as relentless focus on affording innovative products, boosting interconnected customer experience and driving productivity.",0.9371642470359802,0.014141994528472424,0.04869364947080612,positive,0.9230222702026367
9,2018-02-23 05:20:00,Steady housing market recovery and strong customer demand also remain tailwinds.,0.5508856773376465,0.26062843203544617,0.18848590552806854,positive,0.2902572453022003
10,2018-02-23 05:20:00,"Further, the company provided an optimistic view for fiscal 2018.",0.7169737815856934,0.018788304179906845,0.2642379105091095,positive,0.6981855034828186
11,2018-02-23 05:20:00,"Concurrently, it reiterated financial targets for fiscal 2020 and raised the return on invested capital target to reflect gains from the recent tax reform.",0.9003105759620667,0.013808250427246094,0.08588118106126785,positive,0.8865023255348206
12,2018-02-23 05:20:00,"However, gross margins continued to be soft due to impacts from lower margin hurricane-related sales.",0.023710688576102257,0.9555898308753967,0.02069948799908161,negative,-0.9318791627883911
13,2018-02-23 05:20:00,"The company anticipates gross margins to decline in fiscal 2018, excluding the 53rd week, due to tight transportation market.",0.01661904715001583,0.9715684056282043,0.011812573298811913,negative,-0.9549493789672852
14,2018-02-23 05:20:00,"Shares of Glaxo have underperformed the Zacks Large Cap Pharmaceuticals industry over the last year, losing -10.4% versus the industry's +9.7% increase.",0.030759381130337715,0.9592806696891785,0.009960001334547997,negative,-0.9285212755203247
15,2018-02-23 05:20:00,Glaxo beat estimates for both earnings and sales in Q4.,0.9253997206687927,0.04527939110994339,0.02932080067694187,positive,0.8801203370094299
16,2018-02-23 05:20:00,The Zacks analyst likes Glaxo's efforts to develop its pipeline.,0.8138847947120667,0.018860764801502228,0.16725444793701172,positive,0.795024037361145
17,2018-02-23 05:20:00,Performance of new products has been encouraging.,0.9365735054016113,0.01404779776930809,0.04937867075204849,positive,0.9225257039070129
18,2018-02-23 05:20:00,"Meanwhile, back-to-back approvals of three new products -- Trelegy Ellipta, Shingrix and Juluca -- have strengthened Glaxo's competitive position.",0.957230806350708,0.02126082219183445,0.021508391946554184,positive,0.9359700083732605
19,2018-02-23 05:20:00,"However, persistent challenges like stiff competition, genericization, pricing pressure and slowing growth in emerging markets have been hurting sales.",0.020042434334754944,0.9668540954589844,0.013103465549647808,negative,-0.9468116760253906
20,2018-02-23 05:20:00,"Pricing pressure and competitive dynamics are hurting sales in Glaxo's respiratory franchise, particularly the older products.",0.018109558150172234,0.9675588011741638,0.014331606216728687,negative,-0.9494492411613464
21,2018-02-23 05:20:00,"Meanwhile, its top-selling product, Advair is also expected to face generic competition in the United States this year, which will further hurt sales.",0.01876877062022686,0.9685941934585571,0.012636994943022728,negative,-0.9498254060745239
22,2018-02-23 05:20:00,The slowdown in sales of the Consumer Healthcare segment in 2017 is also a concern.,0.017368072643876076,0.9643548130989075,0.018277211114764214,negative,-0.946986734867096
23,2018-02-23 05:20:00,Buy-rated Marriott 's shares have outperformed the Zacks Hotels industry over the last one year.,0.8937364220619202,0.07046929001808167,0.03579426184296608,positive,0.8232671022415161
24,2018-02-23 05:20:00,(the stock is up +63.2% vs. +42.7% gain for the industry).,0.9467198252677917,0.027856919914484024,0.02542329765856266,positive,0.9188628792762756
25,2018-02-23 05:20:00,"Marriott is currently benefiting from Starwood acquisition, rising North-American business, sizeable international exposure and an attractive brand-position.",0.9299185872077942,0.013273244723677635,0.056808121502399445,positive,0.916645348072052
26,2018-02-23 05:20:00,The company also saw upward revisions for 2018 earnings over the last 60 days.,0.6523650288581848,0.038531843572854996,0.3091031312942505,positive,0.6138331890106201
27,2018-02-23 05:20:00,"Notably, with the acquisition of Starwood, Marriott became the world's largest hotel company.",0.8619085550308228,0.012735096737742424,0.12535633146762848,positive,0.8491734862327576
28,2018-02-23 05:20:00,"In fact, this buyout is likely to result in a bigger brand with increased scale and a robust development pipeline in the long run.",0.9282705187797546,0.012890155427157879,0.058839328587055206,positive,0.9153803586959839
29,2018-02-23 05:20:00,"Yet, lingering political uncertainties in key international markets and currency headwinds might continue to limit revenue growth.",0.022117506712675095,0.9596011638641357,0.018281280994415283,negative,-0.9374836683273315
30,2018-02-23 05:20:00,"Moreover, integration risks linked to Starwood purchase is an added concern.",0.03289046883583069,0.4447847306728363,0.522324800491333,neutral,-0.4118942618370056
31,2018-02-23 05:20:00,"Even so, its investments in technology for hotel bookings are anticipated to improve guest experience.",0.9409685730934143,0.015438859350979328,0.04359259828925133,positive,0.9255297183990479
32,2018-02-23 05:20:00,Other noteworthy reports we are featuring today include DISH Network and O'Reilly Automotive.,0.030734451487660408,0.006784170400351286,0.9624813199043274,neutral,0.023950280621647835
33,2018-02-23 05:20:00,More Stock News: This Is Bigger than the iPhone!,0.3262152671813965,0.02558426558971405,0.648200511932373,neutral,0.30063098669052124
34,2018-02-23 05:20:00,It could become the mother of all technological revolutions.,0.3357715904712677,0.018597140908241272,0.6456312537193298,neutral,0.31717443466186523
35,2018-02-23 05:20:00,"Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.",0.5349074602127075,0.016818122938275337,0.4482743740081787,positive,0.5180893540382385
36,2018-02-23 05:20:00,Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it.,0.21044442057609558,0.009386956691741943,0.7801685333251953,neutral,0.20105746388435364
37,2018-02-23 05:20:00,"If you don't buy now, you may kick yourself in 2020.",0.08301617205142975,0.28448015451431274,0.6325036883354187,neutral,-0.201463982462883
38,2018-02-23 05:20:00,"Click here for the 6 trades >>

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.",0.014435051009058952,0.009452740661799908,0.9761122465133667,neutral,0.004982310347259045
39,2018-02-23 05:20:00,Past performance is no guarantee of future results.,0.023727279156446457,0.008731111884117126,0.9675416350364685,neutral,0.01499616727232933
40,2018-02-23 05:20:00,Inherent in any investment is the potential for loss .,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
41,2018-02-23 05:20:00,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
42,2018-02-23 05:20:00,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
43,2018-02-23 05:20:00,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
44,2018-02-23 05:20:00,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
45,2018-02-23 05:20:00,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
46,2018-02-23 05:20:00,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
47,2018-02-23 05:20:00,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
48,2018-02-23 05:20:00,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
49,2018-02-23 05:20:00,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
50,2018-02-23 05:20:00,Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01104306522756815,0.014137434773147106,0.9748194813728333,neutral,-0.0030943695455789566
51,2018-02-23 05:20:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
52,2018-02-23 05:20:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
53,2018-02-23 05:20:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
54,2018-02-23 05:20:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
